Stepan Jerabek is a Postdoctoral Research Scientist at Columbia University in the City of New York since April 2022, specializing in DNA double-strand break repair in early human embryos under the mentorship of Dr. Dieter Egli. Concurrently, Stepan serves as a Scientific Researcher at IOCB Prague. Prior experience includes a Postdoctoral Research Fellowship at Harvard Medical School from December 2017 to September 2020 and a Ph.D. at the Max-Planck Institute for Molecular Biomedicine from 2011 to 2017, with a focus on Cell and Developmental Biology. Stepan completed a Master's degree in General and Applied Biochemistry at the University of Chemistry and Technology in Prague, graduating summa cum laude, and holds a Ph.D. in Biology from the University of Münster, earned magna cum laude.
This person is not in any teams
This person is not in any offices
IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
1 followers
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. Today, over 600 employees including 180 students in 45 research and service groups are involved in a broad spectra of disciplines, which results in more than 250 publications per year, including papers in the most cited prestigious journals such as Nature or Science. The Institute’s emphasis on interaction between chemistry and other sciences leads frequently to medicinal applications. An integral part of the mission of the Institute is, therefore, to transfer the scientific results into assets which help people to live better lives. Together with the research expertise, a system of technology transfer, IP management and commercialization have intensively been built-up. Through its subsidiary company IOCB TTO, the Institute helps scientists to transform ideas into patents and matches their research results with interests of commercial partners to bring novel ideas to human use or technology market.